USP1 has been identified as a deubiquitinating enzyme of the antiapoptotic protein Mcl-1, and ML323, a small molecule inhibitor of USP1, has been shown to increase the sensitivity of CRC cells to DNA-targeted chemotherapeutic agents [133]. Here, MCL1 is linked to colorectal carcinoma.